Obesity in children

Lewis A Barness1

  • 1Pediatrics, University of South Florida School of Medicine, Tampa, FL 33606, USA. lbarness@hsc.usf.edu

Insights

Childhood obesity is a growing health crisis, leading to serious conditions like type 2 diabetes and psychological disorders. Management focuses on appetite regulation and physical activity.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Childhood obesity rates are increasing globally, posing significant health risks.
  • Obesity is linked to type 2 diabetes, cardiovascular diseases, hepatic disorders, skeletal abnormalities, malignancies, and psychological disorders.
  • Appetite and energy metabolism involve complex hormonal (leptin, ghrelin) and neural (neuropeptide-Y) pathways, alongside genetic factors.

Purpose of the Study:

  • To highlight the multifaceted health consequences of childhood obesity.
  • To outline the key physiological mechanisms regulating appetite and energy balance.
  • To emphasize the primary strategies for obesity control.

Main Methods:

  • Review of current literature on childhood obesity.
  • Analysis of hormonal and genetic factors in appetite regulation.
  • Examination of behavioral interventions for weight management.

Main Results:

  • Childhood obesity is associated with a wide range of severe health complications.
  • Hormones like leptin and ghrelin, neuropeptide-Y neurons, and genetics play crucial roles in energy homeostasis.
  • Appetite control and physical exercise are identified as primary methods for obesity management.

Conclusions:

  • Addressing childhood obesity requires a comprehensive approach targeting physiological and behavioral factors.
  • Effective management strategies include dietary interventions and promoting physical activity.
  • Further research into the complex mechanisms of obesity is warranted.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...